Bioresponsive MR contrast agents that non-invasive detect and produce measurable contrast changes for repaired or inserted gene-expression products in living animals, enabling real-time 3D mapping. Designed for gene-therapy developers and preclinical researchers to enable longitudinal monitoring, reduce animal sacrifice, de-risk efficacy and safety assessment, and lower development time and cost.